Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
6.82
+0.13 (1.94%)
At close: May 20, 2026, 4:00 PM EDT
6.95
+0.13 (1.91%)
After-hours: May 20, 2026, 6:57 PM EDT
Arcturus Therapeutics Holdings Employees
As of December 31, 2025, Arcturus Therapeutics Holdings had 111 total employees, including 106 full-time and 5 part-time employees. The number of employees decreased by 65 or -36.93% compared to the previous year.
Employees
111
Change (1Y)
-65
Growth (1Y)
-36.93%
Revenue / Employee
$492,883
Profits / Employee
-$708,748
Market Cap
193.85M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 111 | -65 | -36.93% | 106 | 5 |
| Dec 31, 2024 | 176 | -4 | -2.22% | 174 | 2 |
| Dec 31, 2023 | 180 | 10 | 5.88% | 180 | 0 |
| Dec 31, 2022 | 170 | -7 | -3.95% | 170 | 0 |
| Dec 31, 2021 | 177 | 59 | 50.00% | 177 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Innate Pharma | 174 |
| Fate Therapeutics | 161 |
| Nkarta | 108 |
| Caribou Biosciences | 97 |
| Keros Therapeutics | 78 |
| Cartesian Therapeutics | 75 |
| Milestone Pharmaceuticals | 38 |
ARCT News
- 2 days ago - Arcturus Therapeutics Holdings Transcript: 16th Annual LD Micro Invitational Conference - Transcripts
- 13 days ago - Arcturus Therapeutics Holdings Earnings Call Transcript: Q1 2026 - Transcripts
- 13 days ago - Arcturus Therapeutics Holdings Earnings release: Q1 2026 - Filings
- 13 days ago - Arcturus Therapeutics Holdings Quarterly report: Q1 2026 - Filings
- 13 days ago - Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress - Business Wire
- 23 days ago - Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026 - Business Wire
- 26 days ago - Arcturus Therapeutics Holdings Proxy statement: Proxy filing - Filings
- 2 months ago - Arcturus Therapeutics Holdings Transcript: The 38th Annual Roth Conference - Transcripts